lowdose

Use of low-dose atropine eyedrops (concentration 0.01%) was no better than placebo at slowing myopia (nearsightedness) progression and elongation of the eye among children treated for two years, according to a randomized controlled trial…

A new study analysing data from the landmark ASPREE trial has found that prolonged daily aspirin use increases the risk of anaemia by 20 per cent in people mostly aged 70 and over. The results have prompted researchers to suggest that…

The results of a new clinical trial suggest that the first drug therapy to slow the progression of nearsightedness in kids could be on the horizon. The three-year study found that a daily drop in each eye of a low dose of atropine, a drug…

Moderna’s COVID-19 vaccine works in babies, toddlers and preschoolers the company announced Wednesday — and if regulators agree it could mean a chance to finally start vaccinating the littlest kids by summer.Moderna said in the coming weeks…

Moderna’s COVID-19 vaccine works in babies, toddlers and preschoolers the company announced Wednesday — and if regulators agree it could mean a chance to finally start vaccinating the littlest kids by summer. Moderna said in the…

Pfizer CEO Albert Bourla on Tuesday said he believes the Food and Drug Administration will authorize the company's Covid vaccine for children under 5 years old under a fast-track process that allows the agency to review the data as soon as…

A key Food and Drug Administration advisory committee on Tuesday recommended a lower dose of Pfizer and BioNTech's Covid-19 vaccine for children ages 5 to 11, a critical step in getting some 28 million more kids in the U.S. protected…

Moderna said Monday that a low dose of its COVID-19 vaccine is safe and appears to work in 6- to 11-year-olds, as the manufacturer joins its rival Pfizer in moving toward expanding shots to children. Pfizer's kid-size vaccine doses are…

Moderna said Monday that a low dose of its COVID-19 vaccine is safe and generates an immune response in six- to 11-year-olds, as the manufacturer joins its rival Pfizer in moving toward expanding shots to children. Pfizer-BioNTech's …

Babies could be given Pfizer's Covid vaccine in the US this winter: Company plans to seek approval for jabbing six-month-olds in NovemberPfizer seeking approval to jab kids aged six months to five years by this winterTimeline…